Eledon Pharmaceuticals, Inc. (ELDN) Tops Q4 EPS by 4c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q4 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• (ECBK) Tops Q2 EPS by 39c
• Alpine Income Property Trust, Inc. (PINE) Tops Q2 EPS by 2c; Offers Guidance